Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/GUARD-THERAPEUTICS-INTERN-39435558/news/Guard-Therapeutics-Provides-Updated-Information-on-the-Phase-2-Study-AKITA-43722223/?utm_source=whatsapp&utm_medium=social&utm_campaign=share